BioPharmX Corp·4

Feb 21, 6:35 PM ET

Plott Ronald Todd 4

4 · BioPharmX Corp · Filed Feb 21, 2019

Insider Transaction Report

Form 4
Period: 2019-02-01
Transactions
  • Award

    Option to purchase common stock

    2019-02-01$0.11/sh+133,000$14,630133,000 total
    Exercise: $0.11From: 2019-03-01Exp: 2029-02-01Common stock (133,000 underlying)
  • Award

    Option to purchase common stock

    2019-02-01$0.11/sh+200,000$22,000333,000 total
    Exercise: $0.11From: 2019-03-01Exp: 2029-02-01Common stock (200,000 underlying)
  • Award

    Option to purchase common stock

    2019-02-01$0.20/sh+51,000$10,200418,000 total
    Exercise: $0.20From: 2019-03-01Exp: 2029-02-01Common stock (51,000 underlying)
  • Award

    Option to purchase common stock

    2019-02-01$0.20/sh+34,000$6,800367,000 total
    Exercise: $0.20From: 2019-03-01Exp: 2029-02-01Common stock (34,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 4 months with the first vesting starting on 3/1/2019.
  • [F2]This option vests ratably over 24 months with the first vesting starting on 3/1/2019.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT